Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients

Minerva Cardioangiologica

Volumn 65, Issue 2, 2017, Pages 111-118

  Yang, Lixia ^a   Mu, Lihua ^b   Sun, Linhui ^a   Qi, Feng ^a   Guo, Ruiwei ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b Yunnan Emergency Center   (China)

Author keywords

Nitroprusside; No slow reflow; Primary percutaneous coronary intervention; ST elevation acute myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CONTRAST MEDIUM; HEPARIN; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ADULT; ARTICLE; BALLOON DILATATION; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CONTRAST AGENT REFILLING; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; ELEVATED BLOOD PRESSURE; FEMALE; GUIDING CATHETER; HUMAN; INTRACORONARY DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NO REFLOW PHENOMENON; NONSURGICAL INVASIVE THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; ACUTE DISEASE; AGED; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DRUG EFFECTS; INTRAARTERIAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROCEDURES; ST ELEVATION MYOCARDIAL INFARCTION; STENT;

ACUTE DISEASE; AGED; ANGIOPLASTY, BALLOON; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NITROPRUSSIDE; PERCUTANEOUS CORONARY INTERVENTION; ST ELEVATION MYOCARDIAL INFARCTION; STENTS; VASODILATOR AGENTS;

EID: 85014472220     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: 10.23736/S0026-4725.16.04126-8     Document Type: Article

References (22)

1. Komocsi A, Aradi D, Kehl D, Ungi I, Thury A, Pinter T, et al. Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction. Arch Med Sci 2014;10:203-12.
2. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H, et al. ARandomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI). J Am Coll Cardiol 2014;63:2088-98.
3. Shemirani H, Tafti FD, Amirpour A. Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers. J Res Med Sci 2014;19:1068-73.
4. Berg R, Buhari C. Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory. Curr Cardiol Rev 2012;8:209-14.
5. Forman MB, Hou D, Jackson EK. Treating Acute "No-Reflow" with Intracoronary Adenosine in 4 Patients during Percutaneous Coronary Intervention. Tex Heart Inst J 2008;35:439-46.
6. Jamil G, Jamil M, Abbas A, Sainudheen S, Mokahal S, Qureshi A. "Lone aspiration thrombectomy" without stenting in young patients with ST elevation myocardial infarction. Am J Cardiovasc Dis 2013;3:71-8.
7. Toda N, Tanabe S, Nakanishi S. Nitric Oxide-Mediated Coronary Flow Regulation in Patients with Coronary Artery Disease: Recent Advances. Int J Angiol 2011;20:121-34.
8. Shinozaki N, Ichinose H, Yahikozawa K, Shimada H, Hoshino K. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction. Int heart J 2007;48:423-33.
9. Heupler FA. Contrast-Induced Coronary No-Flow Phenomenon. Tex Heart Inst J 2012;39:162.
10. Eeckhout E, Kern M J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001;22:729-39.
11. Appleby MA, Michaels AD, Chen M, Michael CG. Importance of the TIMI frame count: implications for future trials. Curr Control Trials Cardiovasc Med 2000;1:31-4.
12. Ramjane K, Han L, Jin C. The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol 2008;13:121-8.
13. Balachandran KP, Berry C, Norrie J, Vallance BD, Malekianpour M, Gilbert TJ, et al. Relation between coronary pressure derived collateral flow, myocardial perfusion grade, and outcome in left ventricular function after rescue percutaneous coronary intervention. Heart 2004;90:1450-4.
14. Zhao B, Li J, Luo X, Zhou Q, Chen H, Shi H. The Role of von Willebrand Factor and ADAMTS13 in the No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention. Tex Heart Inst J 2011;38:516-22.
15. Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY, et al. Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis. Eur Heart J 2011;32:2059-66.
16. Akturk IF, Yalcin AA, Biyik I, Caglar NT, Isiksacan N, Sarikamis C, et al. The role of insulin-like growth factor-1 in development of coronary no-reflow and severity of coronary artery disease in patients with acute myocardial infarction. Postepy Kardiol Interwencyjnej 2014;10:12-7.
17. Zhao XJ, Liu XL, He GX, Xu HP. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion. Braz J Med Biol Res 2014;47:245-51.
18. Park S, Lee J, Lee SY, Bae JW, Hwang KK, Kim DW, et al. Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary PercutaneousCoronary Intervention for ST-Segment Elevation Myocardial Infarction. Korean Circ J 2013;43:557-60.
19. Vecchio S, Varani E, Chechi T, Balducelli M, Vecchi G, Aquilina M, et al. Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management. World J Cardiol 2014;6:381-92.
20. Zhao S, Qi G, Tian W, Chen L, Sun Y. Effect of Intracoronary Nitroprusside in Preventing No Reflow Phenomenon during Primary Percutaneous Coronary Intervention: A Meta-Analysis. J Interv Cardiol 2014;27:356-64.
21. Zhao YJ, Fu XH, Ma XX, Wang DY, Dong QL, Wang YB, et al. Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction. Exp Ther Med 2013;6:479-84.
22. Widimsky P, Holmes DRJr. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 2011;32:396-403.